We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 387

Expert "Blinding" is a Question of Relevance, Reliability and Weight, but not Admissibility
  • Borden Ladner Gervais LLP
  • Canada
  • October 12 2016

On August 23, 2016, the Federal Court released its public judgment granting the Order of prohibition for Gilead's ‘619 Patent. The ‘619 Patent


Court dismisses motion for Confidentiality Order
  • Borden Ladner Gervais LLP
  • Canada
  • May 18 2017

The Court dismissed Teva's motion for a confidentiality order. The underlying proceeding is an action by Teva to recover from Janssen and others


The Court grants an innovator standing and the right to be made a party in a judicial Review of the Minister’s Decision relating to the application of the data protection regime
  • Borden Ladner Gervais LLP
  • Canada
  • April 26 2014

This was a motion that raised the issue of an innovator’s standing and right to be made a party to a judicial review of the Minister of Health’s


Decisions in leave to appeal to the Supreme Court
  • Borden Ladner Gervais LLP
  • Canada
  • March 18 2013

The Supreme Court is releasing their judgment for two leave decisions this Thursday. The first, Gilead Science Canada Inc. v. Minister of Health


Appeal relating to double patenting and sufficiency of tadalafil patent dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • November 9 2016

The Federal Court of Appeal considered an appeal from Apotex relating to double patenting and insufficiency of a patent claiming the use of tadalafil


Cross-licensing agreements held to not trigger the requirement to send a Notice of Allegation under the PM(NOC) Regulations
  • Borden Ladner Gervais LLP
  • Canada
  • October 19 2016

The Federal Court of Appeal has overturned two decisions of the Federal Court, relating to the issuance of an NOC to a generic company who did not


Plaintiff granted summary judgment for unpaid royalties
  • Borden Ladner Gervais LLP
  • Canada
  • October 19 2016

The Ontario Court granted the Plaintiff's motion for summary judgment for payment of royalties owing under the licence agreement. The inventor, Arnold


Patent found not to be infringed following construction of the term "independently"
  • Borden Ladner Gervais LLP
  • Canada
  • October 19 2016

Cascade is the owner of a Canadian patent related to a safety locking device for quick couplers and claims that Kinshofer have infringed or induced


Motion for reconsideration denied
  • Borden Ladner Gervais LLP
  • Canada
  • September 30 2013

Sanofi-Aventis had previously been successful in its appeal of a patent infringement decision. Sanofi-Aventis brought the within motion to vary the


Two electrical swtichgear patents are found to be obvious
  • Borden Ladner Gervais LLP
  • Canada
  • September 30 2013

Both of ABB Technology’s patents have been found invalid in an action for infringement. These patents relate to gas insulated switchgear assemblies